Introduction
Cadmium (Cd) is a toxicant, classified as a human carcinogen by the International Agency for Research on Cancer [1] . According to the data provided by the WHO, the daily Cd intake varies in the interval from 40 μg (for people living in unpolluted regions) to 200 μg (for people from polluted areas) [2, 3] . The level at which chronic exposure to Cd is not likely to cause cancer or adverse health effects is 14 μg per day [2, 3] . Cd is a very dangerous environmental pollutant due to its ability to cause severe organ toxicity. When accumulated in the body it induces hepatotoxicity [4] , renal dysfunction [5, 6] , distortion of the reproductive function [7, 8] and cardiovascular injury [9] [10] [11] [12] [13] [14] .
Compounds that possess low toxicity, good absorbability by the gastrointestinal tract and bind toxic metal ions have been used in the chelation therapy for the treatment of toxic metal intoxication [15] [16] [17] . Many chelating agents have been tested to mobilize Cd but no effective chelation therapy is available so far for humans, exposed to Cd intoxication [18] .
It has been discussed that the oxidative stress is one of the mechanisms for the Cd-induced toxicity [19] [20] [21] . Albeit Cd does not generate free radicals by itself it replaces the iron (Fe) and copper (Cu) from cytoplasmic proteins and metalloenzymes [19] . Free iron and copper ions participate in Fenton type reactions leading to the generation of ROS [19] [20] [21] . Other possible mechanism for Cd-induced oxidative stress includes direct interaction of Cd with SH groups of the thiols [20, 21] . In the last years enormous data regarding the application of the antioxidants for the treatment of Cd-induced toxicity have been published [3] .
Herein we present a summary of the antioxidants and chelating agents screened on animal models to decrease Cd concentrations in the body and to prevent Cd-induced oxidative stress. The data presented in this review comprise the period 1992-2012 years. Discussion of the antioxidants and chelating agent tested to inhibit Cd-induced hepatotoxicity, renal dysfunction, testicular toxicity and cardiac impairment is provided.
Effect of antioxidants and chelating agents on Cdinduced hepatotoxicity
The liver and kidneys are critical organs in Cd-induced intoxications. When accumulated in the liver Cd induces inflammatory cell infiltrations, dilation of sinosoids and disorganization of the normal radiating pattern of the hepatocytes around the central vein [22] [23] [24] . At acute and longlasting chronic Cd-intoxications necrosis of the central vein of the liver has been observed [22] .
Antioxidants, tested on animal models for the treatment of Cd-induced hepatotoxicity
The antioxidants tested on animal models to prevent Cdinduced hepatotoxicity are presented in Tables 1 and 2 . As could be seen from the data, presented in both tables, there is an enormous diversity of experimental models, published by authors of studies dealing with the effect of the antioxidants on Cd-induced hepatotoxicity. The antioxidants recover SOD and CAT activity and return to normal the LPO level. [33] In most papers, however, the effect of the antioxidants on Cd-induced oxidative stress in the liver is monitored by the analysis of superoxide dismutase activity (SOD), catalase activity (CAT), gluthathione level (GSH) and level of lipid peroxidation (LPO), expressed as thiobarbituric acid reactive species (TBRAS) or malondyaldehyde (MDA). Cd decreases the level of GSH, and the activity of SOD and CAT in the liver of Cdintoxicated animals and induces a significant increase of LPO. All antioxidants studied have been demonstrated to prevent in some extent Cd-induced oxidative stress in the liver of Cdtreated animals.
Effect of antioxidants on Cd-induced hepatoxicity in animals, subjected to acute and subacute Cd-intoxications
The antioxidants, screened on animal models for the treatment of Cd-induced hepatotoxicity, caused by acute and subacute Cd-exposure, are presented on Table 1 . The combination of three antioxidant results in complete recovery of SOD, CAT, GSH, TBARS and the hepatic enzymes. Normal hepatic architecture is observed in the animals treated with the three antioxidants.
[ 41] Among the antioxidants, presented in the Table 1 , alpha lipoic acid (α-LA), curcumin, Mn-curcumin complex, resveratol and melatonin have been shown not to prevent Cdaccumulation in the liver of Cd-treated animals [25] [26] [27] [28] .
Alpha lipoic acid (α-LA), resveratol and melatonin did not affect Cd-induced decrease of GSH level in the liver, suggesting that these antioxidants might not be the best choice for the treatment of Cd-induced oxidative stress in the liver of animals, subjected to subacute and acute Cd-intoxications [25, 28] . Mncurcumin complex recovers GSH level in the liver but the effect of this antioxidant on the trace element homeostasis especially Fe and Cu should be taken into account when Mn-curcumin complex is applied for the therapy of Cd-induced hepatotoxicity [27] .
Diallyl tetrasulfide [29, 30] , endomorophin 1 [31] , taurine [22] and carnosine [23] have been demonstrated to prevent Cd accumulation in the liver of animals, subjected to acute and subacute Cd-intoxications, as in the case of carnosine administration the effect reaches 87% compared to the normal control. Considerable improvement of the liver morphology by these antioxidants has been observed.
Vitamin E (applied before Cd-intoxication) has been shown to improve the level of GSH in male rats, subjected to acute intoxication with Cd(II) salt [32] . Panax ginseng, ascorbic acid and garlic also improve the total antioxidant capacity of the liver in Cd-treated animals [33, 34] . Detail histological studies about the effect of these antioxidants on the liver morphology of Cd-intoxicated animals are needed to make a conclusion regarding the possible application of these compounds for the treatment of Cd-induced hepatotoxicity.
Effect of antioxidants on Cd-induced hepatotoxicity in subchronically or chronically Cd-intoxicated animals
Diphenyl diselenide [36, 37] , melatonin [38] and hesperetin [24] have been proven to inhibit the level of LPO in the liver of Cd-treated mice. The effect of melatonin [38] however on iron homeostasis should be considered when this antioxidant is utilized for the treatment of Cd-induced hepatotoxicity. Organoselenocyanates [39] have been also effective in restoring the activity of CAT in the liver of Cd-intoxicated animals but the compounds do not recover SOD values. Among the antioxidants screened on animals subchronically or chronically exposed to Cd, naringenin and the combination of naringenin (NGN), vitamin C (Vit C) and vitamin E (Vit E) seem to be the most effective in restoring CAT and SOD activity of the liver (Table 2) [40, 41] . Histopathological analysis of the liver of Cd-intoxicated animals treated with the combination of NGN, Vit C and Vit E has revealed that the antioxidants preserve the normal hepatic architecture.
Effect of chelating agents on Cd-induced hepatotoxicity in mice, subjected to acute and chronic Cd-intoxication
A comparative study on the effect of the chelating agents N- Mi-BDMA (meso-2,3-dimercaptosuccinic acid monoisobutylamide) and Mi-ADMA (meso-2,3-dimercaptosuccinic acid monoisoamylamide) are effective in mobilizing Cd from the liver but are not that much effective in reducing the Cd concentration in the kidneys. At optimum dose Mi-BDMA reduces renal Cd concentration to 40% compared to the toxic control [46] .
Our studies have demonstrated that the polyether ionophorous antibiotic monensin (applied p.o. as tetraethyl ammonium salt) to mice, subjected to subacute Cd-intoxication reduces the concentration of the toxic metal ion in the liver up to 50 %. Furthermore this chelating agent abolished Cdinduced alterations in iron homeostasis and recovered Cu and Zn levels. The data from the histopathological studies showed that monensin attenuated Cd-induced inflammation in the liver confirming the positive effect of the antibiotic on the liver of mice, exposed to subacute Cd intoxication [47, 48] .
3. Antioxidants and chelating agents, screened on animal models for the treatment of Cd-induced renal dysfunction 3.1. Antioxidants 3.1.1. Antioxidants, tested on animal models for the treatment of renal dysfunction, induced by subacute and acute Cd-intoxication
The kidneys are major organs that аccumulate metal ions in cases of metal intoxications. Cd has been shown to induce alterations in creatinine (CR) and urea in the urine and serum of Cd-intoxicated animals [50] . A decrease of the level of the antioxidant enzymes and GSH accompanied with an increase of the LPO in the kidneys of Cd-intoxicated animals has been reported [51, 52] . On the morphological level Cd induces swelling of the epithelial cells of the renal tubules; degeneration and thickening of the basement membrane. Necrosis of the proximal renal tubules has been reported in animals, subjected to acute Cd-intoxication [52] . The antioxidants tested in the period 1992-2012 years for the treatment of Cd-induced renal dysfunction in animals, subjected to acute Cd-intoxication, are presented in Table 4 . Diallyl tetrasulfide recovers the level of CR and urea in the serum and urine of Cd-intoxicated rats. The antioxidant has been demonstrated to act as a chelating agent, reducing the concentration of the toxic metal ion by 70 % compared to the normal control [30] .
Garlic and onion extracts also effectively restore the total antioxidant capacity of the kidneys of Cd-intoxicated animals [50] .
The honey bee, taurine, vitamin C and isoquercetin have been shown to improve the antioxidant defense in the kidneys of animals, exposed to acute Cd-intoxication [51] [52] [53] . Taurine and vitamin C have been demonstrated to recover CR concentration in the serum of mice, subjected to acute Cdintoxication. Both antioxidants decrease MDA level, increase GSH and inhibit the accumulation of Cd in the kidneys. The histopathalogical analysis of kidneys of mice treated with taurine and Vitamin C prior to Cd-intoxication demonstrates that the antioxidants preserve the normal renal architecture. Considering that Vitamin C is an oral drug it might be the best choice for the treatment of acute Cd-intoxication [52] . Caffeic acid also reduces Cd in the kidneys of animals, exposed to subacute Cd-intoxication [54] .
Analysis of the effect of caffeic acid on Cd-induced elevation of Zn concentration in kidneys of Cd-treated animals demonstrates that the antioxidant increases Zn concentration but the values remain lower than the normal controls. Asperagus recemosus, Angrographis paniculata are most effective among eight adaptogens tested. These adaptogens recover GSH; reduce LPO to normal values and decrease Cd in the kidneys by 50 %. The serum CR however remains higher than the normal control.
[61] Monensin improves iron homeostasis and reduces Cd from 50 % (liver) to 90 % (heart).
[47]
Abbreviations: Monoaralkyl esters of meso-2,3-dimercaptusuccinic acid: HOOCCH(SH)CH(SH)COOR, where R = phenylethyl (CH2)2C6H5, MPhEDMS; R = 3-phenylpropyl ((CH2)3C6H5), MPhPDMS; and R = 2-phenoxyethyl (CH2)2OC6H5, MPhOEDMS; Triethylenetetramine dihydrochloride (TRIEN), Tris(2-aminoethyl)amine trihydrochloride (TREN), Tetraethylenepentamine pentahydrochloride (TETRAEN), Pentaethylenehexamine hexahydrochloride (PENTAEN); Alpha-mercapto-beta-(2-furyl) acrylic acid (MFA), alpha-mercapto-beta-(5-sodiumsulfonate, 2-furyl) acrylic acid (MSFA) and alpha-mercapto-beta-(5-acetoxymethyl, 2-furyl) acrylic acid (MAFA); Desferrioxamine (DFO).
It should be pointed out that in contrast to the antioxidants discussed above the caffeic acid has been applied i.p., therefore it might not be the best choice for the treatment of Cdintoxication [54] .
Antioxidants, tested on animal models for the treatment of renal dysfunction, induced by subchronic and chronic Cd-intoxications
The antioxidants screened on animals, exposed to subchronic and chronic Cd-intoxications, are summarized in Table 5 .
N-acetylcysteine (NAC) salt is effective in improving renal function of male and female rats, exposed to chronic Cdintoxication. In both cases however NAC does not recover GSH [55, 56] . Naringenin (NGN), Quercetin (QE), QE+Vitamin C+Vitamin E have been demonstrated to recover CR and urea levels in serum and urine in animals, subjected to subchronic Cdintoxication [57] [58] [59] [60] . Furthermore, these antioxidants decrease LPO in the kidneys and improve GSH and antioxidant enzymes levels. The histopatological analysis of the renal tissue of Cdtreated animals, receiving NGN or QE reveals that these antioxidants preserve the normal renal architecture [57] [58] [59] [60] .
The herbal adaptogens: Withania somnifera, Ocimum sanctum, Asperagus recemosus, Andrographis paniculata, Asphaltum panjabinum (Shilajith), Gymnema sylvestre, Spirulina platensis, and Panex ginseng have been tested to prevent Cd bioaccumulation in chicks, exposed to chronic Cdintoxication [61] . The herbal adaptogens Asperagus recemosus and Andrographis paniculata, applied p.o., reduce Cd concentration in kidney by 50% compared to the control; inhibit LPO, and recover GSH level. CR values in the serum of Cd-treated animals, receiving antioxidants, however remain higher than the normal control (25%) [61] .
Chelating agents
The monoaralkyl esters (HOOCCH(SH)CH(SH)COOR, where R = phenylethyl ((CH2)2C6H5), MPhEDMS; R = 3-phenylpropyl ((CH2)3C6H5), MPhPDMS; and R = 2-phenoxyethyl ((CH2)2OC6H5). MPhOEDMS) of meso-2,3-dimercaptusuccinic acid have been effective in reducing the hepatic and renal Cd concentration in Cd-intoxicated rats, but no information regarding the effect of the chelating agents on the trace elements homeostasis has been presented. Furthermore, the esters of DMSA have been administrated i.p., which could be a disadvantage of these agents over others chelators for the treatment of Cd-intoxication (Table 6 ) [64] .
Among the chelating agents, the polyamines: triethylenetetraamine dihydrochloride (TRIEN), tris(2-amino ethyl)amine trihydrochloride (TREN), tetraethylene pentamine pentahydrochloride (TETRAEN), and pentaethylene hexamine hexahydrochloride (PENTAEN) increase Cd in the urine of Cdexposed rats (Table 5 ) [65] . Oliguria and anuria induced as a result of the application of these chelating agents have been observed in Cd-treated animals, suggesting a significant renal damage [65] .
DMSA and DMPS reduce Cd in the kidneys of mice, exposed to Cd intoxication, but DMSA is not effective in eliminating Cd from intracellular deposits. Therefore this agent is not very suitable for the treatment of chronic Cd-intoxication [46] .
The chelating agents alpha-mercapto-beta-(2-furyl) acrylic acid (MFA), alpha-mercapto-beta-(5-sodiumsulfonate, 2-furyl) acrylic acid (MSFA) and alpha-mercapto-beta-(5-acetoxy methyl, 2-furyl) acrylic acid (MAFA) have been found to be effective in mobilizing Cd in Cd-treated animals, but their affect on trace element homeostasis, especially Cu and Zn, should be considered in chelation therapy with these agents [66] . Hemin restores the active spermatogenesis but the values of testosterone remain lower than the normal control. The antioxidant preserves the normal histoarchitectute of the testes of Cd-treated rats.
[74]
(PhSe)2 p.o. 400 μmol/kg b.w., applied 30 min after Cd-administration Mice, exposed to Cd(II) chloride (5 mg/kg b.w., i.p.)
The antioxidant partially decreases Cd-induced LPO and increases ascorbic acid in the testes. Moderate edema is observed in the testicular tissues of Cdtreated animals, receiving (PhSe)2.
[75]
Vitamin E and Q10 Information not found Information not found Rats, exposed to 0,4 mg/kg Both antioxidants recover GSH, SOD and GR and GSH-Px to normal values. [76] Melatonin i.p. 5 mg/kg b.w. every 8 th hour, beginning 8 hours before Cdadministration Mice, exposed to Cd(II) chloride (2 mg/kg), i.p. The antioxidant inhibits Cd-induced testicular germ cell apoptosis. [77] DFO and monensin are most effective in the elimination of Cd in animals, exposed to acute and subactute Cd-intoxication. Both agents have been demonstrated to improve iron homeostasis and could be applied orally [46, 67] .
Antioxidant and chelating agents, tested on animal models for the treatment of Cd-induced testicular dysfunction
Cd induces reduction of sperm motility, testosterone, 3-β-hydroxysteroiddehydrogenase (3-β-HSD), 17-β-hydroxysteroid dehydrogenase (17-β-HSD) and an increase of the percentage of abnormal sperm in animals, subjected to Cd intoxication. Histopathological analysis of testicular tissue of animals, administrated Cd, reveals that the toxic metal causes severe lesions in the form of diffuse necrosis affecting the germinal layer in the seminiferous tubules and interstitial tissue [70] . Higher levels of lipid peroxidation in testes compared to the normal control have been reported in animals, receiving Cd. Cd decreases the activity of antioxidant enzymes: SOD, CAT and GSH level in the testes [70] .
Antioxidants
4.1.1. Antioxidants, screened on animal models for the treatment of oxidative stress in testes of animals, exposed to acute Cd-intoxication
The antioxidants, screened on animal models for the treatment of oxidative stress in testes of animals, exposed to acute Cd-intoxication, are summarized in Table 7 . Vitamins C and E alone or in combination, applied concurrent with Cdintoxication have been shown to restore testosterone and testicular key androgenic enzymes 3-β-hydroxysteroid dehydrogenase and 17-β-hydroxysteroid dehydrogenase [71, 72] . Depending on the dose of Cd, Vitamins C and E have been demonstrated to recover partially or completely the total antioxidant capacity in the testes. Both vitamins decrease sperm abnormality percentage and improve sperm count [71] [72] [73] 76 ].
Antioxidants, screened on animals for the treatment of oxidative stress in testes of animals, exposed to subchronic and chronic Cd-intoxication
The antioxidants tested on Cd-induced oxidative stress in animals, exposed to subchronic and chronic Cd intoxication, are presented in Table 8 .
Vitamin E and β-carotene improve some hematological paramets (Hb, TEC, TLC) in rats, subjected to subchronic Cdintoxication and significantly recover sperm quality [80, 81] . α-tocopherol reduces the degree of necrosis of the seminiferous tubules induced by 2 mg/kg b.w. Cd(II) chroride, injected i.p. in rats for 5 weeks [78, 79] . The antioxidant however has been demonstrated not to have protective effect in higher doses of Cd(II) chloride [80] and applied before Cd-intoxication.
α-Lipoic acid, applied along with Cd, also recovers testicular key androgenic enzymes and preserves the normal testicular architecture [81] .
Among the antioxidants, screened on animal models for the treatment of Cd-induced toxicity in the testes of animals exposed to subchronic or chronic Cd-intoxication, hesperetin (HP), diallyl tetrasulfide (DTS) and α-tocopherol possess chelating effect, reducing the concentration of toxic metal ion [70, [82] [83] [84] . The protection by these antioxidants is further substantiated by reduction of Cd-induced pathological changes in the testicular tissue.
Chelating agents
The chelating agents screened on animal models for the treatment of Cd-induced toxicity in testes are summarized in Table 9 . Diethyldithiocarbamate (DED) alone decreases Cd concentration in testes, but redistribution of the toxic metal ion to the kidneys and brain has been observed [91, 92] . The combinations of DED and N-benzyl-D-glucamine dithio carbamate (BGD) or DED and N-p-isopropylbenzyl-Dglucaminedithiocarbamate (PBGD) diminish Cd level in testes without causing its redistribution in other tissues [91, 92] . However, these combinations of the chelating agents increase Cd concentration in the blood and Cd distribution in the red blood cells [91, 92] . Disulfiram (DSF) has been demonstrated to be more effective compated to DED in reducing the testicular damage, caused by Cd [93] .
Meso-2,3-dimercaptosuccinic acid (DSMA) applied alone or in combination with (PhSe)2 inhibits the toxicity caused by 2.5 mg/kg b.w. Cd(II) chloride in mice. Both compounds however are ineffective in restoring the SOD activity and the level of ascorbic acid, induced by 5 mg/kg Cd(II) chloride [94] . Diphenyl diselenide applied s.c. 30 min after Cd administration in mice elevates Cd-induced injury in the testes, but when administrated at higher dose (100 μmol/kg), applied alone or together with 2,3-dimercapto-1-propanesulfonic acid (DMPS) decreases Cd-induced toxicity and improves the level of δ-aminolevulinic acid dehydratase (δ-ALA-D) [95, 96] . Monensin reduces Cd concentration in the testes by 50 % compared to the normal control and recovers the histology of the testes to a great extent.
[97] Monensin reduces Cd concentration in the heart by 90% compared to the control and recovers the morphology of the heart.
[ 47] Our results have demonstrated that monensin (applied as tetraethylammonium salt) reduces Cd concentration in the testes of Cd-treated mice by 50 % compared to the control. The administration of the chelating agent to the Cd-intoxicated mice restored the histology of the testes to normal to a great exent [97] .
Antioxidants and chelating agents, tested to inhibit Cdinduced cardiac impairment
Cd is a vascular toxicant that induces hypertension and myocardial hypertrophy. The generation of ROS either by affecting Fe homeostasis or NO level in the endothelial cells has been considered as a primary mechanism for Cd-induced cardiac toxicity.
Cd induces expression of stress genes which in turn alters the activity of the antioxidant enzymes [100] . The antioxidants and chelating agents, screened on animal models to prevent Cdinduced cardiac toxicity, are summarized in Table 10 .
The combination of coenzyme Q (10) and Vitamin E has been demonstrated to reverse Cd-induced alterations in the antioxidant defense system of heart of rats, exposed to acute Cd-intoxication [101] .
Caffeic acid phenyl ester (CAPE) administrated concurrent with Cd prevents the morphological alterations, induced by Cd in the heart of Cd-treated rats by decreasing lipid peroxidation and improving NO homeostasis [100] .
The combination of α-lipoic acid and melatonin applied along with the Cd treatment also inhibits Cd-induced cardiac impairment in rats, subjected to subchronic Cd-intoxication [102] .
Vitamin C and taurine, applied before Cd-intoxication, decrease Cd accumulation in the heart of mice, exposed to subacute Cd-intoxication. Vitamin C is more effective than taurine in preventing the activity of the antioxidant enzymes and the level of GSH in the cardiac muscle. The cardioprotective effect of both antioxidants is substantiated by the reduction of Cd-induced pathological changes in the cardiac tissue [103] .
Among the chelating agents, DMSA and monensin seem to be the most effective in decreasing Cd concentration in the heart of animals, intoxicated with Cd [47, 104] .
2,3-Dimercapto-1-propanesulphonate (DMPS) also decreases Cd concentration in the cardiac muscle of Cd-treated animals. However, precautions should be taken in its application in patients with cardiotoxicity because of its affect on the Ca and Mg concentration in the heart [105].
Conclusion
There are many published reviews on chelating agents and antioxidants tested for the treatment of intoxications with toxic metal ions. To the best of our knowledge however this is the first review that summarizes the literature information published in the last 20 years for the antioxidants and chelating agents, tested on animal models for the treatment of Cdinduced organ toxicity. Detailed information regarding the Cdinduced pathological conditions (hepatotoxicity, renal dysfunction, reproductive disorder and cardiac impairment) is also presented. The data discussed in the review demonstrate the necessity of development of effective scheme for therapy of humans, exposed to Cd-intoxication. Based on the data, presented in this paper, it could be concluded that the simultaneous application of antioxidants and chelating agents could be a good approach for the treatment of Cd-induced organ toxicity. In order to identify the best antioxidant and chelating agent for the treatment of Cd-induced pathological conditions, detailed studies for their effects on different organs in animals, exposed to Cd-intoxications are needed.
